Europe pharmaceutical industry

The prominent position of quantum mechanics led a coterie of academic theoreticians to think that their approach could solve research problems facing the pharmaceutical industry. These theoreticians, who met annually in Europe and on Sanibel Island in Florida, invented the new subfields of quantum biology [45] and quantum pharmacology [46]. These names may seem curious to the uninitiated. They were not meant to imply that some observable aspect of biology or pharmacology stems from the wave-particle... 

Ruffolo R. Re-engineering discovery and development impact on the pharmaceutical industry of tomorrow. In Drug Discovery Technology Europe 2005, IBC Life Sciences. 

Globalization of fhe pharmaceufical industry has created the need to harmonize the recommendations for fhe developmenf of new pharmaceuticals as well as the regulatory requirements. To address this need, in 1990, experts from the pharmaceutical industry and regulators from fhe United States, Europe, and Japan joined together to establish the ICFl... 

The pharmaceutical industry as we know it today started in the late 1800s. It started with the synthetic versions of natural compounds in Europe (refer to Appendix 1). 

The EU has approved Council Directive No. 92/28/EEClO (of 31 March 1992, now consolidated as Articles 86 to 100 of Directive 2001/83/EC) on the advertising of medicinal products for human use, thus bringing Member States into line with common requirements and standards. The UK regulations have been amended to comply with the Directive. The Directive, Part IV of the UK Medicines Act 1968 as amended by the Advertising Regulations, and the ABPl Code of Practice for the Pharmaceutical Industry are broadly in line with one another. The commentary below on promotion relates primarily to the United Kingdom. While there have been some moves towards the international harmonisation of controls on promotion, these have had only a limited effect, despite the fact that in Europe, Member States all comply with Directive 92/28. 

The modern pharmaceutical industry began in Europe when researchers developed methods to isolate and determine the structure of complex chemicals from natural sources, and to build these compounds from inexpensive and readily available starting materials. Soon, industrial chemists were isolating many useful chemicals from coal tar, a by-product of the industrial use of coal for fuel, and developing methods to make many new products, including textile dyes, from scratch. 

ICH home page. The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), a unique project that brings together the regulatory authorities of Europe, Japan and the USA, and experts from the pharmaceutical industry. 

European Federation of Pharmaceutical Industries and Associations (EFPIA) With EFPIA membership from sixteen countries in Western Europe, including all of Europe s major research-based pharmaceutical companies, the Federation s work is concerned with the activities of the EMEA. A wide network of experts and country coordinators has been established to ensure that EFPIA s views are represented in ICH guidelines. 

Apart from natural-product-derived modem medicine, natural products are also used directly in the natural pharmaceutical industry that is growing rapidly in Europe and North America, as well as in the traditional medicine programmes being incorporated into the primary health care systems of Mexico, The People s Repuhhc of China, Nigeria and other developing countries. 

---